Avid Bioservices, Inc. Common Stock
CDMO
CDMO was delisted on the 4th of February, 2025.
99 hedge funds and large institutions have $134M invested in Avid Bioservices, Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 37 increasing their positions, 17 reducing their positions, and 13 closing their positions.
177% more call options, than puts
Call options by funds: $252K | Put options by funds: $91K
118% more repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 17
1% more funds holding
Funds holding: 98 → 99 (+1)
8% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 13
0% more capital invested
Capital invested by funds: $134M → $134M (+$360K)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$5M |
| 2 |
Goldman Sachs
New York
|
+$2.39M |
| 3 |
BlackRock
New York
|
+$840K |
| 4 |
AIC
AWM Investment Company
New York
|
+$791K |
| 5 |
AC
AltraVue Capital
Bellevue,
Washington
|
+$711K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
-$1.82M |
| 2 |
ICM
ISZO Capital Management
New York
|
-$1.51M |
| 3 |
SG Americas Securities
New York
|
-$994K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$533K |
| 5 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
-$302K |
CDMO Hedge Fund Activity: Q3 2019 in Review
99 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in Avid Bioservices, Inc. Common Stock (CDMO) for Q3 2019, worth a combined $134M — up 0.27% from $134M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new CDMO positions and 13 closed out — a net gain of 1 holder — while 37 added to existing stakes and 17 trimmed.
The largest buyer was Millennium Management, adding an estimated $5M. The largest seller was Marshall Wace, exiting entirely with an estimated $1.82M sold.
- 99 institutional investors held Avid Bioservices, Inc. Common Stock (CDMO) as of Q3 2019, up from 98 in Q2 2019.
- Funds reported $134M of Avid Bioservices, Inc. Common Stock stock for Q3 2019, up 0.27% quarter-over-quarter.
- 14 funds opened new Avid Bioservices, Inc. Common Stock positions in Q3 2019 and 13 closed out, a net change of +1 holder.
- The largest Avid Bioservices, Inc. Common Stock buyer in Q3 2019 was Millennium Management, an estimated $5M added.
- The largest Avid Bioservices, Inc. Common Stock seller in Q3 2019 was Marshall Wace, an estimated $1.82M sold.
Based on aggregated 13F filings for Q3 2019.